BACKGROUND: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory coronavirus 2 (SARS-CoV-2), has become a pandemic. This study addresses the clinical and immunopathological characteristics of severe COVID-19. METHODS: Sixty-nine patients with COVID-19 were classified into severe and nonsevere groups to analyze their clinical and laboratory characteristics. A panel of blood cytokines was quantified over time. Biopsy specimens from 2 deceased cases were obtained for immunopathological, ultrastructural, and in situ hybridization examinations. RESULTS: Circulating cytokines, including IL-8, IL-6, TNF-α, IP10, MCP1, and RANTES, were significantly elevated in patients with severe COVID-19. Dynamic IL-6 and IL-8 were associated with disease progression. SARS-CoV-2 was demonstrated to infect type II and type I pneumocytes and endothelial cells, leading to severe lung damage through cell pyroptosis and apoptosis. In severe cases, lymphopenia, neutrophilia, depletion of CD4+ and CD8+ T lymphocytes, and massive macrophage and neutrophil infiltrates were observed in both blood and lung tissues. CONCLUSIONS: A panel of circulating cytokines could be used to predict disease deterioration and inform clinical interventions. Severe pulmonary damage was predominantly attributed to both cytopathy caused by SARS-CoV-2 and immunopathologic damage. Strategies that prohibit pulmonary recruitment and overactivation of inflammatory cells by suppressing cytokine storm might improve the outcomes of patients with severe COVID-19.
BACKGROUND:Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory coronavirus 2 (SARS-CoV-2), has become a pandemic. This study addresses the clinical and immunopathological characteristics of severe COVID-19. METHODS: Sixty-nine patients with COVID-19 were classified into severe and nonsevere groups to analyze their clinical and laboratory characteristics. A panel of blood cytokines was quantified over time. Biopsy specimens from 2 deceased cases were obtained for immunopathological, ultrastructural, and in situ hybridization examinations. RESULTS: Circulating cytokines, including IL-8, IL-6, TNF-α, IP10, MCP1, and RANTES, were significantly elevated in patients with severe COVID-19. Dynamic IL-6 and IL-8 were associated with disease progression. SARS-CoV-2 was demonstrated to infect type II and type I pneumocytes and endothelial cells, leading to severe lung damage through cell pyroptosis and apoptosis. In severe cases, lymphopenia, neutrophilia, depletion of CD4+ and CD8+ T lymphocytes, and massive macrophage and neutrophil infiltrates were observed in both blood and lung tissues. CONCLUSIONS: A panel of circulating cytokines could be used to predict disease deterioration and inform clinical interventions. Severe pulmonary damage was predominantly attributed to both cytopathy caused by SARS-CoV-2 and immunopathologic damage. Strategies that prohibit pulmonary recruitment and overactivation of inflammatory cells by suppressing cytokine storm might improve the outcomes of patients with severe COVID-19.
Entities:
Keywords:
Apoptosis; COVID-19; Infectious disease; Macrophages; Medical statistics; Pulmonology
Authors: Tessa Bergsbaken; Susan L Fink; Andreas B den Hartigh; Wendy P Loomis; Brad T Cookson Journal: J Immunol Date: 2011-07-29 Impact factor: 5.422
Authors: Pui Y Lee; Megan Day-Lewis; Lauren A Henderson; Kevin G Friedman; Jeffrey Lo; Jordan E Roberts; Mindy S Lo; Craig D Platt; Janet Chou; Kacie J Hoyt; Annette L Baker; Tina M Banzon; Margaret H Chang; Ezra Cohen; Sarah D de Ferranti; Audrey Dionne; Saddiq Habiballah; Olha Halyabar; Jonathan S Hausmann; Melissa M Hazen; Erin Janssen; Esra Meidan; Ryan W Nelson; Alan A Nguyen; Robert P Sundel; Fatma Dedeoglu; Peter A Nigrovic; Jane W Newburger; Mary Beth F Son Journal: J Clin Invest Date: 2020-11-02 Impact factor: 14.808
Authors: Sarah W Robison; JinDong Li; Liliana Viera; Jonathan P Blackburn; Rakesh P Patel; J Edwin Blalock; Amit Gaggar; Xin Xu Journal: JCI Insight Date: 2021-04-08